Advertisement

Advertisement

HK:2565 Stock Latest News

PegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout

Company AnnouncementsPegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout

PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate

PremiumCompany Announcements

PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate

18d ago

PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline

PremiumCompany Announcements

PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline

19d ago

PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process

PremiumCompany Announcements

PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process

23d ago

PegBio reshapes board as independent director resigns and new candidate proposed

PremiumCompany Announcements

PegBio reshapes board as independent director resigns and new candidate proposed

1M ago

PegBio outlines board composition and governance committee roles

PremiumCompany AnnouncementsPegBio outlines board composition and governance committee roles

1M ago

PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake

Company Announcements

PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake

2M ago

PegBio Advances H Share Full Circulation Plan After CSRC Filing Approval

Company Announcements

PegBio Advances H Share Full Circulation Plan After CSRC Filing Approval

2M ago

PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026

PremiumCompany Announcements

PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026

3M ago

PegBio overhauls company secretary and governance roles ahead of 2026

PremiumCompany Announcements

PegBio overhauls company secretary and governance roles ahead of 2026

3M ago

PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug

PremiumCompany Announcements

PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug

3M ago

PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China

PremiumCompany Announcements

PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China

3M ago

PegBio sets March 23 board meeting to approve 2025 annual results

PremiumCompany AnnouncementsPegBio sets March 23 board meeting to approve 2025 annual results

3M ago

PegBio Cuts H-Share Board Lot Size to Boost Liquidity

Company Announcements

PegBio Cuts H-Share Board Lot Size to Boost Liquidity

3M ago

PegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial

Company Announcements

PegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial

4M ago

PegBio Formalizes Board Nomination Committee to Bolster Corporate Governance

PremiumCompany Announcements

PegBio Formalizes Board Nomination Committee to Bolster Corporate Governance

6M ago

PegBio Raises HK$300 Million Through H-Share Placing to Fund R&D and Overseas Expansion

PremiumCompany Announcements

PegBio Raises HK$300 Million Through H-Share Placing to Fund R&D and Overseas Expansion

6M ago

PegBio Extends Lock-Up Period, Signaling Investor Confidence

PremiumCompany Announcements

PegBio Extends Lock-Up Period, Signaling Investor Confidence

6M ago

PegBio Co., Ltd. Announces New H Share Placement

PremiumCompany Announcements

PegBio Co., Ltd. Announces New H Share Placement

6M ago

PegBio Co., Ltd. Seeks Approval for H Share Conversion

PremiumCompany AnnouncementsPegBio Co., Ltd. Seeks Approval for H Share Conversion

7M ago

PegBio Extends Lock-up Period, Signaling Investor Confidence

Company Announcements

PegBio Extends Lock-up Period, Signaling Investor Confidence

7M ago

PegBio Co., Ltd. Receives Approval for Innovative Diabetes Drug PB-119

Company Announcements

PegBio Co., Ltd. Receives Approval for Innovative Diabetes Drug PB-119

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >